Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Mal de debarquement (MdD) is a rare otorhinolaryngological disease characterized by a persistent sensation of motion such as rocking, swaying, tumbling and/or bobbing following a period of exposure to passive movement, usually an ocean cruise or other types of water, train, automobile or air travel and less commonly other movements (like sleeping on a waterbed). Onset may be spontaneous in some patients. Manifestations begin shortly after the stimulus, persist for 6 months to years and may be associated with anxiety, fatigue and impaired cognition. Symptoms are often accentuated when in an enclosed space or when attempting to be motionless (sitting, lying down or standing in a stationary position) and are relieved when in passive motion such as in a moving car, airplane or train.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for mal de Debarquement.
21 publications have been identified in PubMed for mal de Debarquement. Research spans Review / Meta-Analysis (29%), Case Report / Case Series (19%), and Clinical Trial Publication (14%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 6 | 29% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 9:26 AM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center
4 |
19% |
Clinical study results | 3 | 14% |
Laboratory research | 3 | 14% |
Disease patterns and progression | 3 | 14% |
Other research | 2 | 10% |
Staab JP (2026). [PMID: 41502326](https://pubmed.ncbi.nlm.nih.gov/41502326/). *Curr Opin Neurol*. [Review / Meta-Analysis]
Ramesh S (2026). [PMID: 41650784](https://pubmed.ncbi.nlm.nih.gov/41650784/). *J Pediatr*. [Other]
Hughes CK (2026). [PMID: 41774616](https://pubmed.ncbi.nlm.nih.gov/41774616/). *Otolaryngol Head Neck Surg*. [Epidemiology / Natural History]
McHugh N (2025). [PMID: 39953586](https://pubmed.ncbi.nlm.nih.gov/39953586/). *Trop Dis Travel Med Vaccines*. [Review / Meta-Analysis]
Schoenmaekers C (2025). [PMID: 40369206](https://pubmed.ncbi.nlm.nih.gov/40369206/). *Exp Brain Res*. [Clinical Trial Publication]
Maruta J (2025). [PMID: 41122084](https://pubmed.ncbi.nlm.nih.gov/41122084/). *Front Neurol*. [Basic Science / Preclinical]
Habeb B (2025). [PMID: 40125111](https://pubmed.ncbi.nlm.nih.gov/40125111/). *Cureus*. [Case Report / Case Series]
Uğur E (2025). [PMID: 40296474](https://pubmed.ncbi.nlm.nih.gov/40296474/). *J Audiol Otol*. [Epidemiology / Natural History]
Cornforth E (2025). [PMID: 40228811](https://pubmed.ncbi.nlm.nih.gov/40228811/). *J Vestib Res*. [Review / Meta-Analysis]
Baron R (2025). [PMID: 40762746](https://pubmed.ncbi.nlm.nih.gov/40762746/). *Curr Neurol Neurosci Rep*. [Review / Meta-Analysis]